| Cat. No. |
Product Name |
CAS No. |
Information |
| PC-43500 |
Cortexolone 17 alpha-propionate
|
19608-29-8 |
Cortexolone 17 alpha-propionate (CB-03-01, Clascoterone) is a topical and peripherally selective androgen antagonist, displays a strong local antiandrogenic activity in hamster's flank organ test, does not exhibit antiandrogenic activity after subcutaneous injection in vivo. |
| PC-62000 |
Enobosarm
|
841205-47-8 |
Enobosarm (GTx-024, MK-2866, Ostarine) is a selective androgen receptor modulator (SARM) for the treatment of conditions such as muscle wasting and osteoporosis. |
| PC-61774 |
VPC 14449
|
1621375-32-3 |
VPC 14449 is a potent and selective androgen receptor DNA-binding domain (AR-DBD) inhibitor with IC50 of 0.34 uM, without affecting AR protein expression. |
| PC-61678 |
EPI-001
|
227947-06-0 |
EPI-001 is a small molecule that blocks transactivation of the androgen Receptor (AR) NTD (IC50=6 uM) and specificly inhibits AR without attenuating transcriptional activities of related steroid receptors. |
| PC-61086 |
BMS-641988
|
573738-99-5 |
BMS-641988 is a potent, selective, nonsteroidal androgen receptor antagonist with Ki of 1.7 nM, MDA-MB-453 cell IC50 of 16 nM. |
| PC-60530 |
Ralaniten acetate
|
1637573-04-6 |
Ralaniten acetate (EPI-506) is the acetate prodrug of Ralaniten (EPI-002), a small-molecule inhibitor of androgen receptor (AR) N-terminal domain inhibitor for the treatment of advanced prostate cancer. |
| PC-60529 |
Ralaniten
|
1203490-23-6 |
Ralaniten (EPI-002) is a novel small-molecule inhibitor of androgen receptor (AR) N-terminal domain inhibitor for the treatment of advanced prostate cancer. |
